Home › Agent Hub › Agent Tools › Part D coverage by drug › Wixela
Agent Tools
Wixela is a brand of fluticasone / salmeterol. What agents check before quoting it: how many 2027 Part D plans cover it, on which tier, with what restrictions and copays, by plan type, carrier and state.
In 2027, 4,857 of 5,492 Medicare Part D and Medicare Advantage drug plans (88.4%) list Wixela on their formulary, across 261 of 286 formularies. The most common placement is tier 3 (2,472 plans, 50.9% of those covering it). 0 of the covering plans require prior authorization (0%), 3 step therapy and 4,729 a quantity limit. Generic fluticasone / salmeterol is on 5,289 of 5,492 plans (96.3%).
2,403 covering plans charge a flat copay for a 30-day supply at a preferred retail pharmacy after the deductible — median $2, 1,088 of them $0; 2,454 charge coinsurance instead — median 22% of the drug's cost. Once a member's out-of-pocket drug spending reaches $2,400 in 2027, covered drugs cost $0 for the rest of the year.
2026: 4,922 of 5,496 plans covered it (89.6%); 2027: 4,857 of 5,492 (88.4%).
Of 4,367 plans offered in both years, 3 added it to the formulary and 121 dropped it.
Among plans covering it both years, 90 moved it to a higher tier and 35 to a lower one; 0 added prior authorization and 0 removed it.
| Tier | Plans |
|---|---|
| Tier 1 | 191 |
| Tier 2 | 2,143 |
| Tier 3 | 2,472 |
| Tier 4 | 51 |
| Plan type | Plans covering | Share | Prior auth |
|---|---|---|---|
| Stand-alone Part D (PDP) | 113 of 323 | 35% | 0% |
| Medicare Advantage with drugs (MA-PD) | 2,908 of 3,200 | 90.9% | 0% |
| Special needs plans (SNP) | 1,836 of 1,969 | 93.2% | 0% |
| Carrier | Plans covering | Usual tier | Prior auth |
|---|---|---|---|
| Humana | 744 of 846 | Tier 3 | 0 |
| UnitedHealthcare | 830 of 830 | Tier 3 | 0 |
| Devoted Health | 728 of 728 | Tier 2 | 0 |
| Aetna Medicare | 631 of 631 | Tier 2 | 0 |
| Wellcare | 0 of 268 | No tier listed | 0 |
| HealthSpring | 186 of 226 | Tier 2 | 0 |
| Kaiser Permanente | 112 of 112 | Tier 2 | 0 |
| SCAN Health Plan | 83 of 83 | Tier 3 | 0 |
| Highmark Blue Cross Blue Shield or Highmark Blue Shield | 0 of 80 | No tier listed | 0 |
| Alignment Health Plan | 77 of 77 | Tier 3 | 0 |
| Anthem Blue Cross and Blue Shield | 74 of 74 | Tier 3 | 0 |
| Wellpoint | 63 of 63 | Tier 3 | 0 |
| Priority Health Medicare | 40 of 40 | Tier 2 | 0 |
| CarePlus Health Plans, Inc. | 37 of 37 | Tier 3 | 0 |
| Zing Health | 36 of 36 | Tier 2 | 0 |
| Capital Blue Cross | 35 of 35 | Tier 3 | 0 |
| Prominence Health Plan | 29 of 29 | Tier 2 | 0 |
| Medica | 1 of 27 | Tier 3 | 0 |
| Anthem HealthKeepers | 26 of 26 | Tier 3 | 0 |
| Blue Cross Blue Shield of Michigan | 26 of 26 | Tier 3 | 0 |
| State | Plans covering | Share |
|---|---|---|
| Alabama | 108 of 114 | 94.7% |
| Alaska | 3 of 9 | 33.3% |
| American Samoa | 1 of 1 | 100% |
| Arizona | 136 of 147 | 92.5% |
| Arkansas | 75 of 85 | 88.2% |
| California | 377 of 397 | 95% |
| Colorado | 100 of 106 | 94.3% |
| Connecticut | 44 of 54 | 81.5% |
| Delaware | 31 of 43 | 72.1% |
| District of Columbia | 12 of 12 | 100% |
| Florida | 510 of 545 | 93.6% |
| Georgia | 128 of 149 | 85.9% |
| Guam | 1 of 1 | 100% |
| Hawaii | 44 of 50 | 88% |
| Idaho | 39 of 45 | 86.7% |
| Illinois | 118 of 132 | 89.4% |
| Indiana | 129 of 138 | 93.5% |
| Iowa | 54 of 64 | 84.4% |
| Kansas | 75 of 84 | 89.3% |
| Kentucky | 108 of 121 | 89.3% |
| Louisiana | 109 of 125 | 87.2% |
| Maine | 42 of 52 | 80.8% |
| Maryland | 43 of 49 | 87.8% |
| Massachusetts | 71 of 89 | 79.8% |
| Michigan | 170 of 182 | 93.4% |
| Minnesota | 44 of 63 | 69.8% |
| Mississippi | 85 of 104 | 81.7% |
| Missouri | 159 of 170 | 93.5% |
| Montana | 21 of 27 | 77.8% |
| Nebraska | 40 of 51 | 78.4% |
| Nevada | 92 of 100 | 92% |
| New Hampshire | 19 of 25 | 76% |
| New Jersey | 64 of 73 | 87.7% |
| New Mexico | 61 of 68 | 89.7% |
| New York | 166 of 215 | 77.2% |
| North Carolina | 164 of 176 | 93.2% |
| North Dakota | 14 of 26 | 53.8% |
| Northern Mariana Islands | 1 of 1 | 100% |
| Ohio | 145 of 171 | 84.8% |
| Oklahoma | 74 of 81 | 91.4% |
| Oregon | 79 of 92 | 85.9% |
| Pennsylvania | 245 of 323 | 75.9% |
| Puerto Rico | 38 of 64 | 59.4% |
| Rhode Island | 23 of 29 | 79.3% |
| South Carolina | 77 of 89 | 86.5% |
| South Dakota | 16 of 30 | 53.3% |
| Tennessee | 128 of 156 | 82.1% |
| Texas | 375 of 407 | 92.1% |
| U.S. Virgin Islands | 1 of 1 | 100% |
| Utah | 47 of 53 | 88.7% |
| Vermont | 8 of 14 | 57.1% |
| Virginia | 138 of 144 | 95.8% |
| Washington | 102 of 114 | 89.5% |
| West Virginia | 55 of 69 | 79.7% |
| Wisconsin | 83 of 96 | 86.5% |
| Wyoming | 7 of 13 | 53.8% |
Medicare Part D paid for 2,076,017 30-day fills of Wixela in 2024 for about 446,560 enrollees, at an average total cost of $94.39 per 30-day fill (CMS Part D Prescribers by Geography and Drug, national).
Price Wixela and the rest of a client's list on every plan in their county.
Free tools for licensed insurance agents. Data from CMS public files; verify with plan documents before advising a client.
Counts are over every Medicare Advantage drug plan and stand-alone Part D plan in the CMS monthly formulary files, excluding employer plans. A plan counts as covering a drug when any strength or form of it is on the plan’s formulary; the tier, prior authorization, step therapy and quantity limit shown are the most favorable version on that formulary. Copays are for a 30-day supply at a preferred retail pharmacy after the deductible. This is a reference for licensed agents, not a plan recommendation; verify with the plan’s formulary before advising a client. Source: CMS Part D formulary files (release 10/08/2026). CMS formulary data.